PMID: 2497511Apr 1, 1989Paper

Immunosuppression by a novel analgesic-opioid agonist

Scandinavian Journal of Immunology
L Hadjipetrou-KourounakisP Kourounakis

Abstract

The effect of a new, centrally acting analgesic, 2-n-pentyloxy-2-phenyl-4- methyl-morpholine (PM) on the humoral antibody isotype responses, mitogenic responses, and interleukin production and assay was studied. Treatment with this opioid agonist exerted a suppressive effect on the antibody responses to TD [sheep red blood cells (SRBC), fluoresceinated human gamma globulin (HGG-FITC)] and TI [fluoresceinated dextran (DEX-FITC), lipopolysaccharide (LPS)]antigens in mice. The suppression was found to be dose- and time-dependent for all antigens tested, suggesting that PM affected both T and B cells. PM impaired lymphocyte functions, as the in vitro T and B mitogen reactions were inhibited in a dose- and time-dependent manner in mice and rats. PM, even at the highest concentration used, could not completely inhibit the production of interleukin 1 (IL-1)-like activity, but it caused complete inhibition, in a dose-dependent manner, of the production of IL-2-like activity. In addition, PM inhibited the assays of both IL-1 and IL-2. Naloxone counteracted all immunosuppressive effects of PM in vivo and in vitro. From this it was concluded that PM operates on the immune system directly, via opioid receptor mechanisms. Our data suggest t...Continue Reading

References

Sep 7, 1979·Science·E HazumP Cuatrecasas
May 1, 1979·Pharmacological Research Communications·W K Ho, A Leung
Aug 1, 1976·European Journal of Immunology·E GronowiczF Melchers
Feb 1, 1986·Molecular and Cellular Biochemistry·G FórisM Hauck
Dec 1, 1987·Biochemical Pharmacology·J J MaddenA Falek
Jan 1, 1988·Life Sciences·E Fiorica, S Spector
Jul 1, 1986·Journal of Neuroimmunology·D J Carr, G R Klimpel
Nov 1, 1985·Clinics in Endocrinology and Metabolism·J E BlalockW J Meyer
Sep 1, 1987·The Journal of Clinical Investigation·P K PetersonW F Keane
Jan 1, 1986·Computers in Biology and Medicine·C J BurgerJ B Birch
Oct 24, 1985·Journal of Immunological Methods·A J GearingR Thorpe
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·H M JohnsonJ E Blalock
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S C GilmanJ D Feldman
Jan 1, 1983·British Medical Bulletin·S J PatersonH W Kosterlitz
May 1, 1983·Clinical Immunology and Immunopathology·J N Mehrishi, I H Mills
Oct 1, 1983·The Journal of Infectious Diseases·E TubaroC Santiangeli
Apr 1, 1983·Drug and Alcohol Dependence·G BocchiniA Canevari
Jan 1, 1983·International Archives of Allergy and Applied Immunology·M Yiagou, L Hadjipetrou-Kourounakis
Aug 1, 1981·The Journal of Experimental Medicine·A Granelli-PipernoE Reich
Apr 26, 1963·Science·N K Jerne, A A Nordin
Feb 1, 1986·Immunology Today·J J OppenheimS K Durum

❮ Previous
Next ❯

Citations

Sep 1, 1990·The International Journal of Neuroscience·E E Karagouni, L Hadjipetrou-Kourounakis
Apr 1, 1990·The International Journal of Neuroscience·P Eliades, L Kourounakis
Jan 1, 1992·Immunopharmacology and Immunotoxicology·J L BussiereT K Eisenstein
Jan 1, 1994·The International Journal of Neuroscience·A GavalasP Kourounakis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.